MRF-Logo2019-Horizontal-RGB
Re: Advice needed treatment options stage 4
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Re: Advice needed treatment options stage 4

› Forums › General Melanoma Community › Advice needed treatment options stage 4 › Re: Advice needed treatment options stage 4

    • August 15, 2010 at 12:27 pm
    James from Sydney
    Participant

      Hi Liz

      Sorry to hear your news, . IL2 was used in Oz but most Doctors have dropped it due as the side effects can be quite severe. In the US they administer the IL2 in an ICU environment. Australia does not seem to have that support set up to look after the patients. I expect its a cost issue.

      Ippilimumab is probably the most promising thing out there although as someone else suggested MEK or NRAS drugs are worth asking about so maybe they could check to see if you have the necessary mutations.

      best wishes

      James.  

    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

    Popular Topics